Schön Klinik Berchtesgadener Land
Schönau am Königssee, Germany
NCT Number: NCT03411876
Aim of this study is to investigate the effects of an Oxymizer pendant nasal cannula in hypoxemic patients with idiopathic pulmonary fibrosis during walking.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Schönau am Königssee, Germany
Patients will be recruited during an inpatient pulmonary rehabilitation program. They will perform three shuttle walk tests on three consecutive days (see below). While performing those tests, the patient's prescribed oxygen flow rate is applicated either through the conventional nasal cannula (CNC) or the Oxymizer.On the first day, patients perform an incremental shuttle walk test to determine maximum walking speed using a conventional nasal cannula.
On two consecutive days, patients will perform two endurance shuttle walk tests at 85% of the maximum incremental shuttle walk test speed. Supplemental oxygen will be provided via nasal cannula at the prescribed oxygen flow rate. Patients will be randomly assigned to perform one test with the Oxymizer and the other one with a conventional nasal cannula.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supplemental oxygen is provided by an Oxymizer pendant nasal cannula.
Supplemental oxygen is provided by a conventional nasal cannula.
Time frame: at baseline, at isotime of endurance shuttle walk test and at the end (maximum 20 min) of endurance shuttle walk test
Distance patients walk during an endurance shuttle walk test
Time frame: at baseline, at isotime of endurance shuttle walk test and at the end (maximum 20 min) of endurance shuttle walk test
measured by Sentec Digital Monitoring System
Time frame: at baseline, at isotime of endurance shuttle walk test and at the end (maximum 20 min) of endurance shuttle walk test
measured by Sentec Digital Monitoring System
Time frame: at baseline, at isotime of endurance shuttle walk test and at the end (maximal 20 min) of endurance shuttle walk test
measured by NoxT3 device
Time frame: at baseline, at isotime of endurance shuttle walk test and at the end (maximum 20 min) of endurance shuttle walk test
transcutaneously carbon dioxide pressure measured by Sentec Digital Monitoring System
Time frame: From beginning of endurance shuttle walk test until the oxygen saturation reaches defined thresholds, or ESWT reaches maximum time frame of 20 minutes
time (seconds) is measured until oxygen saturation drops below 90% or 85 % respectively
Klaus Kenn
Other
Effects of an Oxymizer Pendant Cannula Versus a Conventional Nasal Cannula During Endurance Shuttle Walk Test (ESWT) in Hypoxemic Patients With Idiopathic Pulmonary Fibrosis
Acronym: IPF/Oxymizer2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02846324
Hypoxemia, Hypoxia
Birmingham, Alabama, United States
View Trial DetailsNCT05028894
Albinism, Albinism, Oculocutaneous
Sunnyvale, California, United States
View Trial DetailsNCT06135363
Fibrosis, Idiopathic Pulmonary Fibrosis
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT02688647
Fibrosis, Idiopathic Interstitial Pneumonias
Phoenix, Arizona, United States
View Trial Details